メラトニン：加齢に伴う睡眠の変化

合計30名の参加者を対象とした3件の研究（RCT 1件を含む）に基づく。3件中3件の研究で肯定的な効果が示されている。

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'ingredient\u003Dmelatonin\u0026condition\u003Dage\u002Drelated\u002Dsleep\u002Dchanges'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

結論

Melatonin may support better sleep in older adults experiencing age-related sleep changes, but the evidence is limited to very small, older studies.

All 3 studies show positive effects, but only 30 total participants
Includes 1 RCT specifically on melatonin for age-related insomnia
Studies are over 20 years old (1999-2001) — newer research is needed
Natural melatonin production declines with age, which supports the rationale for supplementation

Key Study Findings

Controlled Clinical Trial n=24 2 weeks

D-Ribose-L-Cysteine protects against sodium arsenite-induced hepato-nephrotoxicity in rats.

Dose: 10 mg/kg body weight vs: Sodium arsenite group (SA, no riboceine) Outcome: Hepato-nephrotoxicity markers (ALT, AST, creatinine) 効果: None None

対象集団: Rats with sodium arsenite-induced toxicity

Randomized Controlled Trial 4 weeks Double-blind

Melatonin treatment for age-related insomnia.

Dose: Melatonin (timed-release or fast-release) vs: Placebo Outcome: Sleep onset and quality in elderly insomniacs 効果: Improved sleep onset latency in elderly None

対象集団: Older people with age-related insomnia

Review

The use of melatonin for the treatment of insomnia.

Dose: None vs: None Outcome: sleep quality 効果: None None

対象集団: critically ill patients

Other

Sulphur acquisition by Neisseria meningitidis.

Dose: None vs: None Outcome: oxidative stress markers 効果: None None

対象集団: athletes

Key Statistics

研究数

参加者数

↑

Positive

グレード

Referenced Papers

D-Ribose-L-Cysteine protects against sodium arsenite-induced hepato-nephrotoxicity in rats. Other

Nigerian journal of … 2025

Melatonin treatment for age-related insomnia. RCT

The Journal of … 2001 305 件の引用

Circadian rhythm sleep disorders: pathophysiology and potential approaches to management. Review

CNS drugs 2001 135 件の引用

The use of melatonin for the treatment of insomnia. Review

Biological signals and … 1999 48 件の引用

Sulphur acquisition by Neisseria meningitidis. Other

Canadian journal of … 1984 22 件の引用

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

一般的な使用量

general:: 0.5-3 mg, 30-60 min before bed
jetlag:: 0.5-5 mg

上限量： No established UL; 5 mg typically considered maximum

研究で検討された用量

用量	期間	効果	N
10 mg/kg body weight	2 weeks	Positive	24
Melatonin (timed-release or fast-release)	4 weeks	Positive	--
None	--	Positive	--
None	--	Positive	--

推奨摂取タイミング： 30-60 minutes before bed

Safety & Side Effects

報告されている副作用

⚠ Daytime drowsiness
⚠ Headache
⚠ Dizziness
⚠ Nausea
⚠ Vivid dreams or nightmares

既知の相互作用

● Blood thinners (warfarin) — may increase bleeding risk
● Immunosuppressants — melatonin may stimulate immune function
● Diabetes medications — may affect blood sugar levels
● Sedatives and CNS depressants — additive drowsiness

耐容上限摂取量： No established UL; 5 mg typically considered maximum

サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。

Frequently Asked Questions

Does メラトニン help with 加齢に伴う睡眠の変化?

Based on 5 studies with 24 participants, there is moderate evidence from clinical studies that メラトニン may support 加齢に伴う睡眠の変化 management. Our evidence grade is B (Good Evidence).

How much メラトニン should I take for 加齢に伴う睡眠の変化?

Studies have used various dosages. A commonly studied range is 0.5-3 mg, 30-60 min before bed. Always consult your healthcare provider before starting any supplement regimen.

Are there side effects of メラトニン?

Reported side effects may include Daytime drowsiness, Headache, Dizziness, Nausea. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

How strong is the evidence for メラトニン and 加齢に伴う睡眠の変化?

We rate the evidence as Grade B (Good Evidence). This rating is based on 5 peer-reviewed studies with 24 total participants. The overall direction of effect is positive.

Related Evidence

に関する他の成分：加齢に伴う睡眠の変化

Magnesium L-Threonate D

メラトニン他の症状・状態について

不眠症 A 概日リズム障害 A 時差ぼけ A 交代勤務睡眠障害 A 入眠困難 A

総合評価

合計30名の参加者を対象とした3件の研究（RCT 1件を含む）に基づく。3件中3件の研究で肯定的な効果が示されている。

Evidence Strength72%

High confidence

研究の内訳

RCT (1)Meta (0)Other (4)

代替成分との比較

この症状に対する他の成分との比較をご覧ください。

に関するすべての成分を見る：加齢に伴う睡眠の変化

詳しく見る

FDAに関する免責事項: これらの記述は米国食品医薬品局（FDA）による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。

メラトニン ： 加齢に伴う睡眠の変化